Saranac Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.34M Buy
20,032
+66
+0.3% +$24.5K 2.43% 14
2026
Q1
$5.36M Buy
19,966
+2,145
+12% +$639K 2.29% 18
2025
Q4
$5.88M Buy
17,821
+3,347
+23% +$1.13M 2.3% 23
2025
Q3
$5M Buy
14,474
+1,617
+13% +$489K 0.91% 35
2025
Q2
$4.01M Buy
12,857
+997
+8% +$381K 2.13% 26
2025
Q1
$6.21M Buy
11,860
+1,282
+12% +$655K 3.53% 7
2024
Q4
$5.35M Buy
+10,578
New +$6.01M 2.95% 12
2024
Q3
– Sell
-11,251
Closed -$5.73M – 68
2024
Q2
$5.73M Sell
11,251
-127
-1% -$62.2K 3.41% 6
2024
Q1
$5.63M Buy
11,378
+786
+7% +$400K 3.44% 6
2023
Q4
$5.58M Sell
10,592
-5,283
-33% -$2.82M 3.68% 5
2023
Q3
$8M Buy
15,875
+28
+0.2% +$13.8K 4.5% 6
2023
Q2
$7.62M Buy
15,847
+1,269
+9% +$621K 4.04% 7
2023
Q1
$6.89M Buy
14,578
+10,492
+257% +$5.06M 4.06% 7
2022
Q4
$2.17M Buy
+4,086
New +$2.16M 3.93% 8

Other funds holding UNH

Saranac Partners's UNH Position: Q2 2026 in Review

Saranac Partners increased its UnitedHealth (UNH) stake by 0.33% in Q2 2026, buying an estimated $24.5K and bringing the position to 20,032 shares worth $8.34M. The position accounts for 2.43% of the portfolio, ranked #14.

Saranac Partners first reported a position in UNH in Q4 2022 and has held it in 14 quarters since. 3,394 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Saranac Partners held 20,032 shares of UnitedHealth worth $8.34M as of Q2 2026.
  • Saranac Partners bought 66 UnitedHealth shares in Q2 2026, an estimated $24.5K.
  • UnitedHealth made up 2.43% of Saranac Partners's portfolio in Q2 2026, its #14 holding.
  • Saranac Partners first reported a position in UnitedHealth in Q4 2022 and has held it in 14 quarters since.
  • 3,394 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.